Reading room
The long and the short of it.
Books above, field notes below. The same argument at two lengths: in most of these cases the science held, and what failed was the system around it.
Books
Field notes
All field notes →· Intellectual property
A note on the decision nobody had to defend
Britain never patented the monoclonal antibody method. The referral was made before publication. What failed was a decision nobody was exposed to.
· Technology transfer
A note on the middle nobody counts
US technology transfer counted 28,278 disclosures and 10,277 licenses in FY2025. The work between those two numbers has no line in any report.
· University–industry collaboration
A note on industry's share of research
Qatar's business sector funds about 13% of research and innovation. That number, not the headline R&D figure, decides what technology transfer can do.
· Intellectual property
A note on what a patent cannot protect
The CT scanner was invented, patented and Nobel-recognized in Britain, and General Electric ended up selling it. What that gap says about how we value a patent.
· Research commercialization
A note on the statistic that built technology transfer
The number that argued for Bayh-Dole, fewer than 5% of 28,000 federal patents licensed, has no traceable source. What that says about how we measure our field.